article thumbnail

In Brain Chemistry We Trust—The Gospel According to Pharma

Mad in America

Depression was sold to us as a simple problem of serotonin insufficiency, a convenient narrative that made drug companies like Eli Lilly, Forest Pharmaceuticals, and Pfizer very rich. As a former pharmaceutical advertising writer, I not only witnessed the explosive growth in antidepressant drugs, I contributed to it.

article thumbnail

Antidepressant Use Linked to Sexual Dysfunction, Why Aren’t Prescribers Discussing It?

Mad in America

Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine. Maelys Touya was an employee of Lundbeck LLC, and Lambros Chrones was an employee of Takeda Pharmaceuticals U.S.A., The study was authored by Judith J. Additionally, Anita H.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Psychotherapy and Psychosomatics: End of an Era for Independent Journals? An Interview With Giovanni Fava

Mad in America

Third, his journal told of the corrupting influence of pharmaceutical money on the creation of psychiatric diagnoses and drug trials. Whitaker: There are those two funding sources, open access where people have to pay, or journals where they’re basically funded by pharmaceutical advertisements. Fava: Right, and the libraries.

article thumbnail

Summing up the STAR*D Scandal: The Public was Betrayed, Millions were Harmed, and the Mainstream Media Failed Us All

Mad in America

In our 2015 book Psychiatry Under the Influence , Lisa Cosgrove and I wrote about the STAR*D scandal in depth, as it served as an example of the institutional corruption in psychiatry due to pharmaceutical interests and psychiatrys own guild interests. The 12 STAR*D authors listed a collective total of 151 ties to pharmaceutical companies.

article thumbnail

Robert Whitaker Answers Reader Questions on Pharma Marketing and Psychiatric Drugs

Mad in America

For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Moore: The last couple of questions are related to the pharmaceutical industry. Then we got juvenile bipolar disorder. How about the kids?

article thumbnail

Real World Evidence and Cannabis Psychosis

Real Psychiatry

health and wellness industry compared with the total pharmaceutical industry value of $602B. Exclusion criteria included any previous diagnosis of substance induced psychosis, schizophrenia, or bipolar disorder. Rhetoric is always a significant factor in the United States, especially when there are large sums of money at stake.

Legal 104
article thumbnail

One Person’s Journey from Celebrity Medical Model Advocate to Skeptic: An Interview with Rose Cartwright

Mad in America

You write that you worry about how psychedelics are getting co-opted by pharmaceutical industries. At home there was a constant level of ambient chaos. I saw a lot of distressing things when I was very young and into my 20s. You want to be reborn in each moment. That’s the whole Buddhist philosophy. Tell us more.